Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Change in Account Payables of -$186000.0 for Q4 2025, down 2557.14% year-over-year from $7569.8 in Q4 2024, and down 167.88% quarter-over-quarter from $274000.0 in Q3 2025.
Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025) Analysis & Trends
Pulse Biosciences' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$186000.0 for Q4 2025.
- In Q4 2025, Change in Account Payables fell 2557.14% year-over-year to -$186000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 663.18% YoY), while the FY2025 annual figure was $1.1 million, up 663.18% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$186000.0, down from $274000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $712000.0 in Q1 2025, with the low at -$1.5 million in Q2 2022.
- The 5-year median for Change in Account Payables is $64000.0 (2022), against an average of $52500.0.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables jumped 6855.56% in 2021, then slumped 2557.14% in 2025.
- Pulse Biosciences' Change in Account Payables stood at $185000.0 in 2021, then slumped by 321.08% to -$409000.0 in 2022, then soared by 206.85% to $437000.0 in 2023, then tumbled by 101.6% to -$7000.0 in 2024, then plunged by 2557.14% to -$186000.0 in 2025.
- Business Quant data shows PLSE's Change in Account Payables at -$186000.0 in Q4 2025, $274000.0 in Q3 2025, and $332000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -186,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Sep 30, 2023 | -386,000.00 |
| Sep 30, 2023 | -386,000.00 |